MedTrace Logo

Assessment of Respiratory Dysfunction in Obesity and the Use of IMT.

NCT07307417 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-14

No results posted yet for this study

Summary

The aim of the project will be to assess the functional condition of the respiratory tract and inflammation resulting from obesity, as well as the possibility of using inspiratory muscle training as a factor reducing the occurrence of dysfunction in the respiratory system.

Conditions

Interventions

DEVICE

inspiratory muscle training

The IMT experimental group will undergo training with a load of 30% of PImax, assessed in the first inspiratory muscle strength test. Training will be conducted twice a day, with 30 breaths in each training session. From the second week onwards, the training load will be increased by 10% each week. The maximum load will be 60% of PImax. The intervention will last 6 weeks and will be performed daily.

DEVICE

placebo-IMT

The control group will perform simulated inspiratory muscle training with a constant load of 15% PImax. Training will take place 7 times a week, 60 breaths once a day. The intervention will last 6 weeks and will be performed daily.

Sponsors & Collaborators

  • Wroclaw University of Health and Sport Sciences

    lead OTHER

Principal Investigators

  • Dariusz Kałka, prof. · Wroclaw University of Health and Sport Sciences

  • Krystyna Rożek-Piechura, prof. · Wroclaw University of Health and Sport Sciences

  • Paulina Okrzymowska · Wroclaw University of Health and Sport Sciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-25
Primary Completion
2026-10-31
Completion
2026-11-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07307417 on ClinicalTrials.gov